Richard Kang - Jun 9, 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
Director
Signature
/s/ Richard Kang
Stock symbol
NRBO
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 05:25 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Nonstatutory Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 9, 2022 Common Stock 20K $0.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests on the earlier of June 9, 2023 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.